Dr. Reddy's releases generic OraceaGeneric Oracea is indicated for the treatment of inflammatory lesions of rosacea in adult patients. Alvotech to manufacture Humira biosimilar for Quallent Pharmaceuticals The high-concentration interchangeable biosimilar to AbbVie Biotechnology's Humira manufactured by Alvotech will be distributed under Quallent’s private-label. Sponsored 3 Ways to Maximize Rebates with Compliance Insights Discover The Ultimate Tool for Pharmacy Purchasing Precision and Compliance Intuity Medical’s POGO Automatic Blood Glucose Monitor now covered by Medicare CMS has established new Medicare coverage codes for the automatic blood glucose monitor. FDA approves Boehringer Ingelheim’s high-concentration formulation of interchangeable Humira biosimilar Cyltezo, the company’s interchangeable biosimilar to Humira, is used to treat multiple chronic inflammatory diseases. Sandoz reaches agreement with Amgen on denosumab biosimilars The agreement clears the path for the launch of Jubbonti and Wyost on May 31, 2025, or earlier under certain circumstances. Aetna provides more than $40K to support health initiatives in Oklahoma The investments will provide sports equipment for youth across the state, as well as health and wellness initiatives for communities in central Oklahoma. Aurobindo receives FDA OK for generic Mitigare Colchicine Capsules are indicated prophylaxis of gout flares in adults. Hy-Vee dietitians offering free anemia screenings throughout May Hy-Vee dietitians will offer additional events throughout the month to support customers’ wellness journeys. CVS Health reports Q1 results, revises full-year 2024 guidance CVS Health's total revenues increased to $88.4 billion in the first quarter, up 3.7% compared to the prior year period. First Previous 73 74 75 76 77 Next Last
